Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Steroid withdrawal relief: new study tests hydrocortisone for lingering fatigue

NCT ID NCT05193396

First seen Nov 01, 2025 · Last updated May 18, 2026 · Updated 29 times

Summary

This study tests whether a low-dose hormone called hydrocortisone can relieve symptoms like fatigue and dizziness in people who have recently stopped taking steroids for giant cell arteritis or polymyalgia rheumatica. About 100 adults aged 50 and older will receive either hydrocortisone or a placebo for 16 weeks. The goal is to see if this treatment improves quality of life during the recovery period.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADRENAL INSUFFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital

    RECRUITING

    Aarhus, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Endocrinology, Odense University Hospital

    RECRUITING

    Odense, 5230, Denmark

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Department of Nephrology and Endocrinology, Rigshospitalet

    RECRUITING

    Copenhagen, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.